Immunogenicity of the BA.5 Bivalent mRNA Vaccine Boosters

Waning immunity following mRNA vaccination and the emergence of SARS-CoV-2 variants has led to reduced mRNA vaccine efficacy against both symptomatic infection and severe disease. Bivalent mRNA boosters expressing the Omicron BA.5 and ancestral WA1/2020 Spike proteins have been developed and approve...

Descripción completa

Detalles Bibliográficos
Autores principales: Collier, Ai-ris Y., Miller, Jessica, Hachmann, Nicole P., McMahan, Katherine, Liu, Jinyan, Apraku Bondzie, Esther, Gallup, Lydia, Rowe, Marjorie, Schonberg, Eleanor, Thai, Siline, Barrett, Julia, Borducchi, Erica N., Bouffard, Emily, Jacob-Dolan, Catherine, Mazurek, Camille R., Mutoni, Audrey, Powers, Olivia, Sciacca, Michaela, Surve, Nehalee, VanWyk, Haley, Wu, Cindy, Barouch, Dan H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9628195/
https://www.ncbi.nlm.nih.gov/pubmed/36324798
http://dx.doi.org/10.1101/2022.10.24.513619

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9628195/
https://www.ncbi.nlm.nih.gov/pubmed/36324798
http://dx.doi.org/10.1101/2022.10.24.513619

Ejemplares similares